Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  pan-RAF kinase inhibitor MLN2480
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Study of MLN2480 in Patients With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Patients With Metastatic Melanoma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: C28001, NCI-2013-00851, 13/SC/0007, 2012-003397-16, U1111-1164-7508, NCT01425008
Start Over